NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

A few mentions of Germany from the nwbo 10-K.

NOL in the United Kingdom and Germany of $15.6 million and $15.2 million respectively do not expire over time.

During 2018, we transferred our European manufacturing to the UK, and terminated such activities in Germany.

We also lease and occupy approximately 915 square feet of office space in Germany. The lease covering this property is currently scheduled to expire in December 2020.

So clearly there is not much nwbo activity in Germany now, but at some point there was sufficient activity to generate $15.2m in NOLs. Perhaps that amount is the root of the tax issue? It's the only thing I see in the 10-K that relates to both Germany and taxation.